Apyx Medical Corp Share Price Nasdaq
Equities
US03837C1062
Medical Equipment, Supplies & Distribution
Sales 2024 * | 49.94M 3.98B | Sales 2025 * | 54.52M 4.35B | Capitalization | 48.5M 3.87B |
---|---|---|---|---|---|
Net income 2024 * | -27M -2.15B | Net income 2025 * | -25M -1.99B | EV / Sales 2024 * | 0.97 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.89 x |
P/E ratio 2024 * |
-1.79
x | P/E ratio 2025 * |
-2.01
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.08% |
Latest transcript on Apyx Medical Corp
Managers | Title | Age | Since |
---|---|---|---|
Charles Goodwin
CEO | Chief Executive Officer | 58 | 14/12/17 |
Andrew Makrides
FOU | Founder | 82 | 31/12/77 |
Matthew Hill
DFI | Director of Finance/CFO | 56 | 12-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Makrides
FOU | Founder | 82 | 31/12/77 |
Lawrence Waldman
BRD | Director/Board Member | 77 | 14/03/11 |
Craig Swandal
BRD | Director/Board Member | 63 | 08/03/18 |
1st Jan change | Capi. | |
---|---|---|
-3.43% | 184B | |
-1.81% | 107B | |
-4.15% | 67.78B | |
+1.43% | 50.66B | |
+11.60% | 47.64B | |
+4.60% | 41.12B | |
+3.03% | 26.3B | |
+3.21% | 26.04B | |
+15.06% | 25.4B |